Prince Technologies

What Prince Technologies does

Prince Technologies B.V. is a privately held Dutch specialist in Capillary Zone Electrophoresis (CZE) instrumentation, headquartered in Emmen, the Netherlands, founded in 1993, and operating with a headcount of approximately 25 employees. The company designs, develops, manufactures and services modular analytical instruments — the current flagship PrinCE Next|800 Series (models 840, 850, 870, 875) and the legacy PrinCE/-C 700 Series — for high-resolution separation, identification and quantification of analytes by size, shape and charge. Its product surface spans the instruments themselves, four software packages (WinPrinCE, DAx, DAx 3D, and Clarity for PrinCE Next — the last of which supports 21 CFR Part 11 compliance for regulated environments), a detector portfolio (Diode Array, Conductivity, Laser-Induced Fluorescence, Mass Spectrometry interface), and a comprehensive consumables and kits catalogue (vials, capillaries, buffers, CE-Sure validation kits).

The company's business model is a multi-stream analytical-instrument sale plus recurring aftermarket model: hardware sales of CE systems and detectors, one-time software licenses (often bundled with systems), recurring consumables and kit sales, bespoke method development services, and OEM/licensing arrangements in which platform components are embedded into partners' products (notably FIDA-Tech's FIDAlyzer). Go-to-market combines direct enterprise sales with regional distributors (e.g., APG Bio in China) and OEM agreements, targeting pharmaceutical and biopharmaceutical customers (therapeutic monoclonal antibody charge-variant analysis), academic and industrial research institutions, and QC/process-monitoring laboratories worldwide. The firm holds ISO 13485:2016 certification (audited by LRQA) covering IVD and chemical-lab instrument operations, enabling sales into regulated medical-device and biopharma environments. Prince Technologies is the only company in the world, by its own claim, focused exclusively on capillary electrophoresis, and sells globally to analytical and clinical customers through distributorships and OEM licensees.

Name

Prince Technologies

Legal name

Prince Technologies B.V.

Website

https://princetechnologies.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Prince Technologies B.V. is a privately held Dutch manufacturer founded in 1993 that designs, builds and services modular Capillary Electrophoresis (CZE) instruments, software, detectors and consumables, serving biopharmaceutical, research and QC laboratories worldwide.

Ownership category

akta.pro rank

Product category

Analytical Instruments (Capillary Electrophoresis)

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823)

akta.pro primary industry

Analytical Instruments & Chromatography Systems (HLAGAIAA)

akta.pro secondary industry

Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB)

Keywords

• Capillary electrophoresis systems
• Analytical instruments
• Biopharmaceutical testing
• Lab software solutions
• Scientific consumables

Headquarters

HQ city

Emmen

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Capillary Electrophoresis Systems: Sale of CE instruments including PrinCE Next|800 series (840, 850, 870, 875 models). High-performance analytical instruments with modular design for various applications.
2. Software Licenses: Four advanced software packages: WinPrinCE, DAx, DAx 3D, and Clarity for PrinCE Next. Software comes standard with systems or as separate purchase.
3. Consumables and Accessories: Comprehensive catalogue of vials, caps, capillaries, lamps, buffers, kits and accessories. Includes CE-Sure kits for anion/cation separation.
4. Detectors: Sale of detectors including DAD, Conductivity and LIF options. Flexibility in coupling devices such as detectors, power supplies or special sample preparation devices.
5. Method Development Services: Tailored, bespoke support for method development. Team advises on buffer chemistries, hardware configurations, software features and manufacturing.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Prince Technologies designs, manufactures and sells modular Capillary Electrophoresis (CE) instruments — notably the PrinCE Next|800 Series and PrinCE/-C 700 Series — along with supporting detectors, software packages, consumables and bespoke method development services for analytical and clinical customers worldwide. The systems provide high-performance separation, identification and quantification for size, shape and charge analysis in pharmaceutical, biopharmaceutical, research and quality-control applications.

Product overview

Prince Technologies offers a modular family of Capillary Electrophoresis (CE) systems consisting of two main product lines: the PrinCE/-C 700 Series (legacy) and the PrinCE Next|800 Series (current flagship). The PrinCE Next|800 Series includes four models (840, 850, 870, 875) ranging from start-up to fully automated systems, all supporting modular configurations. The product portfolio encompasses multiple detector types (Diode Array Detector, Conductivity, Laser-Induced Fluorescence, Mass Spectrometry), four software packages (WinPrinCE, Dax, Dax 3D, Clarity for PrinCE Next) for instrument control and data analysis, and comprehensive consumables including vials, capillaries, buffers, and validation kits. Prince Technologies also provides method development services and OEM partnerships, with the FIDAlyzer (by FIDA-Tech) representing a notable OEM product built on the PrinCE Next platform.

Differentiator

Problem solved

Functional benefit

Brands

• PrinCE Next|800 Series: Flexible portfolio of Capillary Electrophoresis analysers with modular and configurable design specifications.
• PrinCE Next|840
• PrinCE Next|850
• PrinCE Next|870
• PrinCE Next|875
• PrinCE-C Series
• WinPrinCE
• DAx
• DAx 3D
• Clarity for PrinCE Next
• FIDAlyzer

Products and services

• PrinCE Next|800 Series

Quantifiable outcome

• Rapid charge variant analysis with high analytical throughput compared to HPLC-Ion Exchange Chromatography or imaged Capillary Isoelectric Focusing

Named customers1 record

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature5 records

Partnerships

Three partnerships are on record, tiered regional, core and minor.

• APG BioregionalChannel Partner/ Reseller/ Distributor · 28 March 2018Chinese distributor for Prince Technologies products. Exhibiting at CHINA LAB 2018 expo in Guangzhou to represent Prince Technologies in the Chinese market.
• FIDA-TechcoreOEM/ Whitelabel/ Licensing Partner · 1 January 2018OEM Partner using PrinCE Next platform as basis for FIDAlyzer - a revolutionary technology for protein analysis. FIDA-Tech won the Basel Life 2018 Product Innovation Award for this product. The FIDAlyzer provides rapid, precise information on binding, size and concentration of proteins based on Taylor Dispersion Analysis theory.
• LRQAminorOthers · 1 January 2016Leading certification provider for ISO 13485:2016 certification of Prince Technologies for design, development, production, sales and service of In-Vitro Diagnostic instruments and instruments for Chemical Laboratories.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Agilent Technologies: Agilent offers the 7100 Capillary Electrophoresis system alongside its dominant HPLC and mass spectrometry portfolio; it competes with Prince across analytical labs and is the broad instrument incumbent in many of the same accounts.
• Thermo Fisher Scientific: Through its Analytical Instruments segment, Thermo offers CE-on-a-chip (ZipChip) and adjacent ion chromatography/mass spec workflows, competing for the same biopharma and academic characterization budgets.
• Bio-Rad Laboratories: Bio-Rad supplies protein analysis and life science research tools, including capillary electrophoresis and imaging platforms used in similar biopharma QC and academic labs.
• Waters Corporation: Waters' ACQUITY and ion chromatography family competes with Prince for charge and size-based analysis work, while its broader Empower platform pressures Prince's software/data strategy.

Direct peers

• SCIEX (Danaher): SCIEX sells the PA 800 Plus capillary electrophoresis platform for biopharmaceutical characterization, directly competing with Prince's PrinCE Next systems for the same mAb and protein analysis customers.
• Beckman Coulter Life Sciences (Danaher): Historical leader in capillary electrophoresis with the PA 800 and earlier P/ACE MDQ platforms serving biopharma and clinical labs; competes head-to-head with Prince in protein and ion analysis workflows.
• Helena Laboratories: Helena markets clinical capillary electrophoresis instruments (e.g., V8 Nexus) for protein and hemoglobin analysis, an adjacent competitor in the clinical/IVD corner of the same CE market.
• Sebia: Sebia's Capillarys and Hydrasys systems apply capillary electrophoresis in clinical diagnostics, paralleling Prince's clinical/IVD positioning and ISO 13485 certified manufacturing footprint.

Emerging players

• Analytik Jena (Endress+Hauser): Analytik Jena's contraction and capillary electrophoresis product lines (formerly part of its life science tools portfolio) compete for routine ion and small-molecule CE applications in industrial and academic labs.
• ProteinSimple (Bio-Techne): ProteinSimple's Maurice and Wes systems use CE-based charge and size analysis for biologics, increasingly competing with Prince's PrinCE Next for biopharma characterization and QC use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/princetechnologies

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prince Technologies